202 related articles for article (PubMed ID: 27578002)
21. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
22. The pluripotency factor Nanog is directly upregulated by the androgen receptor in prostate cancer cells.
Kregel S; Szmulewitz RZ; Vander Griend DJ
Prostate; 2014 Nov; 74(15):1530-43. PubMed ID: 25175748
[TBL] [Abstract][Full Text] [Related]
23. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
24. Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.
Myers JS; Vallega KA; White J; Yu K; Yates CC; Sang QA
BMC Cancer; 2017 Jul; 17(1):480. PubMed ID: 28697756
[TBL] [Abstract][Full Text] [Related]
25. Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 gene.
Barnabas N; Xu L; Savera A; Hou Z; Barrack ER
Prostate; 2011 Jun; 71(8):857-71. PubMed ID: 21456068
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.
He Y; Mi J; Olson A; Aldahl J; Hooker E; Yu EJ; Le V; Lee DH; Kim WK; Robins DM; Geradts J; Sun Z
Oncogene; 2020 Apr; 39(16):3276-3291. PubMed ID: 32089544
[TBL] [Abstract][Full Text] [Related]
27. lncRNA MNX1‑AS1 promotes prostate cancer progression through regulating miR‑2113/MDM2 axis.
Liang D; Tian C; Zhang X
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616155
[TBL] [Abstract][Full Text] [Related]
28. Multi-ethnic transcriptome-wide association study of prostate cancer.
Fiorica PN; Schubert R; Morris JD; Abdul Sami M; Wheeler HE
PLoS One; 2020; 15(9):e0236209. PubMed ID: 32986714
[TBL] [Abstract][Full Text] [Related]
29. SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer.
Audet-Walsh É; Vernier M; Yee T; Laflamme C; Li S; Chen Y; Giguère V
Mol Cancer Res; 2018 Sep; 16(9):1396-1405. PubMed ID: 29784665
[TBL] [Abstract][Full Text] [Related]
30. Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans.
Shiina M; Hashimoto Y; Kulkarni P; Dasgupta P; Shahryari V; Yamamura S; Tanaka Y; Dahiya R
BMC Cancer; 2021 Sep; 21(1):1028. PubMed ID: 34525952
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-mRNA Regulatory Network Mediates Activation of mTOR and VEGF Signaling in African American Prostate Cancer.
Gujrati H; Ha S; Mohamed A; Wang BD
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328346
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of p16 expression among African American and European American prostate cancer patients.
Wong M; Bierman Y; Pettaway C; Kittles R; Mims M; Jones J; Ittmann M
Prostate; 2019 Aug; 79(11):1274-1283. PubMed ID: 31111520
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
34. Tumor immunobiological differences in prostate cancer between African-American and European-American men.
Wallace TA; Prueitt RL; Yi M; Howe TM; Gillespie JW; Yfantis HG; Stephens RM; Caporaso NE; Loffredo CA; Ambs S
Cancer Res; 2008 Feb; 68(3):927-36. PubMed ID: 18245496
[TBL] [Abstract][Full Text] [Related]
35. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression.
Chen JL; Li J; Kiriluk KJ; Rosen AM; Paner GP; Antic T; Lussier YA; Vander Griend DJ
Clin Cancer Res; 2012 Aug; 18(16):4291-302. PubMed ID: 22723371
[TBL] [Abstract][Full Text] [Related]
37. Association of Anthropometric Measures with Prostate Cancer among African American Men in the NCI-Maryland Prostate Cancer Case-Control Study.
Pichardo MS; Smith CJ; Dorsey TH; Loffredo CA; Ambs S
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):936-944. PubMed ID: 29784730
[No Abstract] [Full Text] [Related]
38. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
[TBL] [Abstract][Full Text] [Related]
39. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.
Sanchez TW; Zhang G; Li J; Dai L; Mirshahidi S; Wall NR; Yates C; Wilson C; Montgomery S; Zhang JY; Casiano CA
Mol Cell Proteomics; 2016 Dec; 15(12):3564-3580. PubMed ID: 27742740
[TBL] [Abstract][Full Text] [Related]
40. Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer.
Schayek H; Bentov I; Jacob-Hirsch J; Yeung C; Khanna C; Helman LJ; Plymate SR; Werner H
Horm Metab Res; 2012 Jun; 44(7):511-9. PubMed ID: 22495974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]